| Mrs Adrian M Stahl, SLP-CCCS | |
|
12311 Ashley Dr Ste A, Gulfport, MS 39503-2950 | |
| (228) 357-5253 | |
| (662) 349-8757 |
| Full Name | Mrs Adrian M Stahl |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 12311 Ashley Dr Ste A, Gulfport, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356881593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | S4283 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Adrian M Stahl, SLP-CCCS 83 Airways Pl, Southaven, MS 38671-5885 Ph: (662) 349-8787 | Mrs Adrian M Stahl, SLP-CCCS 12311 Ashley Dr Ste A, Gulfport, MS 39503-2950 Ph: (228) 357-5253 |
News Archive
A surprise discovery that could lead to new treatments for herpes viruses that infect more than 90 percent of the world's adult population has led to a $1.8 million grant to the University of Arkansas for Medical Sciences (UAMS) from the National Cancer Institute (NCI) at the National Institutes of Health (NIH).
Rising mortality rates among pensioners aged 85 and over are linked to reductions in spending on income support for poorer pensioners, suggests new research published today by the Journal of the Royal Society of Medicine.
A new paper just published in the Journal of Bioethical Inquiry uses extensive Freedom of Information Act findings to detail an extremely troubling off-label medical intervention employed in the U.S. on pregnant women to intentionally engineer the development of their fetuses for sex normalization purposes.
Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.
› Verified 8 days ago
Ellen Saizan, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 15465 Oak Ln Ste 100c, Gulfport, MS 39503 Phone: 228-344-0078 | |
Ms. Laurie B Johnson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Beach Dr, Gulfport, MS 39507 Phone: 228-897-4452 Fax: 228-388-0017 | |
Mrs. Megan Logan Bounds, MS/CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 12303 Highway 49, Gulfport, MS 39503 Phone: 228-832-6221 Fax: 228-832-4033 | |
Carrie Joyce Payne-morris, MSCCC-SLP,MPH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14553 S Country Wood Dr, Gulfport, MS 39503 Phone: 228-861-0584 | |
Mrs. Joanna Maria-arnold Adcock, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1423 Magnolia St Apt D, Gulfport, MS 39507 Phone: 228-256-6015 Fax: 228-206-6978 | |
Emily Hagin Weems, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16128 Orange Grove Rd, Gulfport, MS 39503 Phone: 228-365-8992 | |
Stephanie Tapp, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16411 Robinson Rd, Gulfport, MS 39503 Phone: 228-539-9984 Fax: 228-539-9984 |